已妊娠女性肾脏疾病组织学表现与长期结局的多中心队列研究
该多中心队列研究分析了1997至2012年间21家医院育龄女性(16至<50岁)的 native 肾活检,将妊娠期或产后1年内因尿检异常/肌酐升高而活检的173例与1000例非妊娠对照按年龄和种族匹配。妊娠相关组FSGS更常见(32.4% vs 9.7%,P<0.001),且随访期eGFR下降风险更高(OR 1.67,95%CI 1.03-2.71,P=0.04),但需RRT或死亡无差异。
要点
- 妊娠相关肾活检中FSGS占32.4%,显著高于对照组的9.7%(P<0.001)。
- 妊娠相关组随访期eGFR下降的OR为1.67(95%CI 1.03-2.71,P=0.04)。
- 两组需RRT或死亡无差异;妊娠相关组eGFR年下降更速(-1.33 vs -0.56 ml/min/1.73m²,P=0.045)。
核心结论
- 妊娠是发现肾脏疾病的机会;已妊娠女性FSGS较对照更常见,妊娠期或产后1年内发现的肾病后续更易出现肾功能下降。
- 需进一步工作以确定妊娠是启动、加重还是揭示肾脏疾病。
研究设计与样本
- 多中心队列研究,纳入1997至2012年21家医院育龄女性(16至<50岁)的 native 肾活检。
- 妊娠相关诊断组为妊娠期或产后1年内因尿检异常/肌酐升高而活检者,与对照按年龄和种族(黑人 vs 非黑人)匹配。
- 共173例妊娠相关活检(19例产前,154例产后)与1000例对照匹配。
主要发现
- FSGS在妊娠相关活检中占32.4%,高于对照组的9.7%(P<0.001),但Columbia分型无差异。
- 妊娠相关诊断组较对照更年轻(32.1 vs 34.2岁,P=0.004),黑人比例更高(26.0% vs 13.3%,P<0.001),但FSGS女性中种族无差异。
- 妊娠相关组(除外产前活检)随访期CKD-EPI eGFR下降的OR为1.67(95%CI 1.03-2.71,P=0.04),eGFR年下降更速(-1.33 vs -0.56 ml/min/1.73m²,P=0.045)。
- 两组需RRT或死亡无差异。
局限性
- 需进一步工作以确定妊娠是启动、加重还是揭示肾脏疾病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: For many women pregnancy is the first contact with health services, thus providing an opportunity to identify renal disease. This study compares causes and long-term renal outcomes of biopsy-proven renal disease identified during pregnancy or within 1 year postpartum, with nonpregnant women. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Native renal biopsies (1997-2012), in women of childbearing age (16 to <50 years), from 21 hospitals were studied. The pregnancy-related diagnosis group included those women with abnormal urinalysis/raised creatinine identified during pregnancy or within 1 year postpartum. Pregnancy-related and control biopsies were matched for age and ethnicity (black versus nonblack). RESULTS: One hundred and seventy-three pregnancy-related biopsies (19 antenatal, 154 postpregnancy) were identified and matched with 1000 controls. FSGS was more common in pregnancy-related biopsies (32.4%) than controls (9.7%) (P<0.001) but there were no differences in Columbia classification. Women with a pregnancy-related diagnosis were younger (32.1 versus 34.2 years; P=0.004) and more likely to be black (26.0% versus 13.3%; P<0.001) than controls, although there were no differences in ethnicities in women with FSGS. The pregnancy-related group (excluding antenatal biopsies) was more likely to have a decline in Chronic Kidney Disease Epidemiology Collaboration eGFR in the follow-up period than the control group (odds ratio, 1.67; 95% confidence interval, 1.03 to 2.71; P=0.04), and this decline appeared to be more rapid (-1.33 versus -0.56 ml/min per 1.73 m2 per year, respectively; P=0.045). However, there were no differences between groups in those who required RRT or who died. CONCLUSIONS: Pregnancy is an opportunity to detect kidney disease. FSGS is more common in women who have been pregnant than in controls, and disease identified in pregnancy or within 1 year postpartum is more likely to show a subsequent decline in renal function. Further work is required to determine whether pregnancy initiates, exacerbates, or reveals renal disease.
引用
- Webster P, Webster LM, Cook HT, et al. A Multicenter Cohort Study of Histologic Findings and Long-Term Outcomes of Kidney Disease in Women Who Have Been Pregnant. Clin J Am Soc Nephrol. 2016. PMID: 27940459. doi:10.2215/CJN.05610516
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。